THE STONEBRIDGE PRACTICE
150 HILLTOP AVENUE, LONDON
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 0 | 0 | NA% | |
| CKD 4 | 2008 | 12 | 12 | 100.0% | |
| CKD 5 | 2009 | 7 | 8 | 87.5% | |
| CKD 5 | 2010 | 13 | 14 | 92.9% | |
| CKD 5 | 2011 | 21 | 24 | 87.5% | |
| CKD 5 | 2012 | 18 | 21 | 85.7% | |
| CKD 5 | 2013 | 19 | 21 | 90.5% | |
| CKD003 | 2014 | 18 | 21 | 85.7% | |
| CKD003 | 2015 | 17 | 18 | 94.4% | |
| NM84 | 2016 | 15 | 19 | 78.9% | |
| NM84 | 2017 | 15 | 19 | 78.9% | |
| NM84 | 2018 | 14 | 19 | 73.7% | |
| NM84 | 2019 | 9 | 16 | 56.2% | |
| NM84 | 2020 | 9 | 23 | 39.1% | |
| NM84 | 2022 | 6 | 15 | 40.0% | |
| NM84 | 2023 | 10 | 20 | 50.0% |
